the "who's" of genomic markers: who to re biopsy
Published 7 years ago • 122 plays • Length 14:50Download video MP4
Download video MP3
Similar videos
-
17:33
the "who's" of genomic markers: who to biopsy
-
12:53
the "who's" of genomic markers: who to treat
-
33:52
the use of genomic markers and prostate biopsy decisions
-
12:05
genomic markers and dna sequencing testing
-
26:20
mapping pathology as a guide to focal therapy the role of mapping biopsies and tissue markers
-
2:17
genomic markers in prostate cancer
-
11:03
biomarkers for prostate cancer: whom to treat
-
8:53
pro: the role of currently available biomarkers genomics in risk stratification of prostate cancer
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
16:56
improving specificity of psa screening w/ serum & urine markers: who doesn’t need a prostate biopsy?
-
20:48
mri in the enhanced detection of prostate cancer: what urologists need to know
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
13:25
progess in understanding pathology of prostate cancer
-
10:13
the role of genetic testing in prostate cancer
-
14:05
integrating mri and molecular markers to detect aggressive prostate cancer
-
20:50
active surveillance 2021 - from bench to bedside
-
23:37
active surveillance who is the right patient and what is the right protocol
-
7:14
genetic testing for bladder cancer - urology care foundation